- The Supreme Court said that economic policy could not take precedence over the lives of citizens, as it questioned the Union government about its approach to regulating the prices of essential medicines and medical products.
- The National Pharmaceutical Pricing Authority (NPPA), the government’s drug-price regulator, capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of their maximum retail price (MRP).
- Trade margins are the difference between the price at which a medicine is purchased and the price at which it is sold by intermediaries such as distributors, retailers or hospitals. Read More
Drug Price Control: Right to Health vs “Calibrated” Regulation
Context
Background